CD44 and neoplasm: Attempts to isolate BCSCs based on the basal cell surface marker CD44 expression-despite being closely associated with tumor progression and aggressiveness- showed substantial variation among basal tumor subtypes and have been at least unsuccessful in non-muscle-invasive tumors [35,36,37].